BXPHARMA share price
Beximco Pharmaceuticals PLC. · Pharmaceuticals & Chemicals · Category A
Price
Closing prices, 19 Nov 2026 Live prices free with an account
- Previous close
- ৳149.40
- Day range
- No trade
- Volume
- 0
- Turnover
- —
BXPHARMA price over the last year
Daily closing prices from DSE, not adjusted for bonus or rights issues.
Reported earnings and NAV
| Period | EPS | NAV / share | NOCFPS |
|---|---|---|---|
| FY27 Q1 | 5.72 | 144.90 | 8.06 |
| FY26 Annual | 20.17 | 139.18 | 21.33 |
| FY26 Q3 | 4.98 | 134.60 | 16.74 |
| FY26 Q2 | 5.28 | 129.63 | 11.16 |
| FY26 Q1 | 5.30 | 124.34 | 6.14 |
| FY25 Annual | 15.56 | 119.04 | 16.19 |
| FY25 Q3 | 3.86 | 115.21 | 9.46 |
| FY25 Q2 | 4.10 | 111.35 | 6.13 |
Per-share figures in taka, as published on DSE. Interim EPS is for the period, not annualised.
Latest DSE announcements
-
Trading of the shares of the company will resume on 22-Nov-2026.
-
Trading of the shares of the company will remain suspended on record date i.e., 19-Nov-2026.
-
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 17.11.2026 to 18.11.2026 and trading of the shares will remain suspended on record date i.e., 19.11.2026.
-
The company has informed that the Board of Directors in its meeting held on November 12, 2026 has approved the appointment of Mr. S. M. Rabbur Reza as a Director and Managing Director of the company with immediate effect.
-
(Q1 Un-audited): Consolidated EPS was Tk. 5.72 for July-September 2026 as against Tk. 5.30 for July-September 2025. Consolidated NOCFPS was Tk. 8.06 for July-September 2026 as against Tk. 6.14 for July-September 2025. Consolidated NAV per share was Tk. 144.90 as on September 30, 2026 and Tk. 124.34 as on September 30, 2025.
-
The company has informed that the Board of Directors, in its meeting held on 12 November 2026, approved the incorporation of a new company under the proposed name Beximco Pharma Nutraceuticals Ltd., as a wholly owned subsidiary of the Company. The proposed subsidiary will engage in the manufacturing and marketing of herbal medicinal products as part of Beximco Pharma's strategy to diversify its product portfolio and expand its presence in the healthcare market. (cont.1)
Other Pharmaceuticals & Chemicals shares
| Ticker | Price | % | Turnover |
|---|---|---|---|
| ASIATICLABAsiatic Laboratories Limited | 116.70 | +1.83% | ৳16.3Cr |
| WATACHEMWata Chemicals Limited | 183.10 | +8.22% | ৳11.0Cr |
| SQURPHARMASquare Pharmaceuticals PLC. | 209.70 | -0.29% | ৳8.4Cr |
| ACMELABThe ACME Laboratories Limited | 77.50 | -3.73% | ৳3.2Cr |
| ORIONINFUOrion Infusion Ltd. | 202.80 | -0.44% | ৳2.9Cr |
| ACMEPLACME Pesticides Limited | 24.50 | -0.41% | ৳2.8Cr |
BXPHARMA: common questions
What is BXPHARMA's share price?
BXPHARMA closed at ৳149.40 on the Dhaka Stock Exchange (Closing prices, 19 Nov 2026), 0.00 (0.00%) from the previous close of ৳149.40.
What is BXPHARMA's 52-week high and low?
Between 23 Nov 2025 and 18 Nov 2026, BXPHARMA traded as high as ৳158.50 and as low as ৳99.50 on DSE.
What is BXPHARMA's P/E ratio?
At ৳149.40, BXPHARMA's P/E ratio is 7.41, on its FY26 earnings per share of ৳20.17.
What dividend did BXPHARMA declare?
For 2026, Beximco Pharmaceuticals PLC. declared a 60% cash dividend. Percentages are of the ৳10 face value.
Which sector is BXPHARMA in?
Beximco Pharmaceuticals PLC. is listed in the Pharmaceuticals & Chemicals sector of the Dhaka Stock Exchange, in category A.
Prices, trades and company figures are from the Dhaka Stock Exchange; prices are at least 15 minutes old. Trakkr is not affiliated with DSE, and nothing here is investment advice.